The groundbreaking approach of tirzepatide peptide represents a significant development in the management of type 2 diabetes. Distinct from existing medications, tirzepatide affects two pathways – GLP-1 and the GIP https://tirzepatide-peptide119526.myparisblog.com/42627980/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment